Legacy Venture Capital

Legacy Venture Capital is a venture capital firm investing in early-stage life science companies addressing complex diseases.

Founded by Tiffany Pham and Diane Shao, the firm focuses on supporting innovators in building inclusive, world-changing companies that address widespread human health needs. Their investment strategy targets immunologic, metabolic, mental, genetic, and reproductive health sectors, aiming to intervene early in addressing complex disorders through cutting-edge technologies like AI and molecular-based solutions.

The firm invests between $500,000 and $5 million in pre-seed, seed, and Series A stage companies. Their deal flow comes from an extensive network of founders, executives, colleagues, alumni, and other VCs, as well as collaborations with technology transfer offices from universities like MIT and Cornell. This approach reflects their commitment to driving positive change in the world by bridging the gap between groundbreaking research and commercial success in the life sciences sector.